Edwards Lifesciences Corp. buy Royal Bank of Canada
Start price
01.08.23
/
50%
€74.66
Target price
01.08.24
€87.48
Performance (%)
7.81%
Price
10.05.24
€80.49
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada shows slight gains of 7.81%. This prediction currently runs until 01.08.24. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Edwards Lifesciences Corp. | 1.629% | 1.629% |
iShares Core DAX® | 4.094% | 3.543% |
iShares Nasdaq 100 | 1.424% | 0.512% |
iShares Nikkei 225® | -1.572% | -4.633% |
iShares S&P 500 | 1.822% | 0.963% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Edwards Lifesciences Corp. diskutieren
Edwards Lifesciences Co. (NYSE: EW) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $96.00 price target on the stock.
Ratings data for EW provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Edwards Lifesciences Corp.
Edwards Lifesciences Corp.
Start price
Target price
Perf. (%)
€83.96
15.04.24
15.04.24
€95.04
15.04.25
15.04.25
-4.13%
10.05.24
10.05.24
Edwards Lifesciences Corp.
Start price
Target price
Perf. (%)
€80.68
07.02.24
07.02.24
€88.24
07.02.25
07.02.25
-0.24%
10.05.24
10.05.24
Edwards Lifesciences Corp.
Start price
Target price
Perf. (%)
€67.68
12.01.24
12.01.24
€74.84
12.01.25
12.01.25
18.93%
10.05.24
10.05.24
Edwards Lifesciences Corp.
Start price
Target price
Perf. (%)
€60.38
26.10.23
26.10.23
€77.62
26.10.24
26.10.24
33.31%
10.05.24
10.05.24
Edwards Lifesciences Corp.
Start price
Target price
Perf. (%)
€71.40
17.08.23
17.08.23
€88.14
17.08.24
17.08.24
12.73%
10.05.24
10.05.24